Compugen (CGEN) EBIT Growth (3y) (2012 - 2026)
Compugen (CGEN) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 79.65% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 | -3.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.82% |
| Dec 31, 2025 | 161.49% |
| Sep 30, 2025 | 13.54% |
| Jun 30, 2025 | -42.32% |
| Mar 31, 2025 | 42.02% |
| Dec 31, 2024 | 5.19% |
| Sep 30, 2024 | 39.42% |
| Jun 30, 2024 | -29.02% |
| Mar 31, 2024 | 41.40% |
| Dec 31, 2023 | 58.45% |
| Sep 30, 2023 | -11.05% |
| Jun 30, 2023 | -69.62% |
| Mar 31, 2023 | 49.92% |
| Dec 31, 2022 | 19.21% |
| Sep 30, 2022 | -22.37% |
| Jun 30, 2022 | 82.48% |
| Mar 31, 2022 | -4.48% |
| Dec 31, 2021 | 3.19% |
| Sep 30, 2021 | -23.87% |
| Jun 30, 2021 | 2.78% |